The need for costly clinical trials in order to bring a drug successfully to market is undoubtable. However, outside of this carefully controlled, highly supportive environment, the real world actualities are very different. In today’s healthcare environment, where competitive products are coming to market within months of each other; there is limited differentiation in clinical efficacy; and pricing strategies are very similar, payers are increasingly expecting the industry to differentiate their products by delivering services beyond the pill. Paul Tanner, Chairman of 90TEN Healthcare invite us to take a journey from Clinical Trial to Real World Outcomes.